Katarzyna Tomela

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Ejection Fraction

Saccharomyces Cerevisiae

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut mycobiota dysbiosis is associated with melanoma and response to anti-PD-1 therapy. Cancer immunology research (2024)
Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik-Schmidt, Łukasz Galus, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Adam Mackiewicz, Marcin Schmidt
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition. Cancers 14 (21) (2022)
Katarzyna Tomela, Justyna A Karolak, Barbara Ginter-Matuszewska, Michal Kabza, Marzena Gajecka
Influence of TGFBR2, TGFB3, DNMT1, and DNMT3A Knockdowns on CTGF, TGFBR2, and DNMT3A in Neonatal and Adult Human Dermal Fibroblasts Cell Lines. Current issues in molecular biology 43 (1) (2021)
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik-Schmidt, Andrzej Mackiewicz, Marcin Schmidt
Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells. International journal of molecular sciences 21 (23) (2020)
Justyna A Karolak, Barbara Ginter-Matuszewska, Katarzyna Tomela, Michal Kabza, Dorota M Nowak-Malczewska, Malgorzata Rydzanicz, Piotr Polakowski, Jacek P Szaflik, Marzena Gajecka
Further evaluation of differential expression of keratoconus candidate genes in human corneas. PeerJ 8 (2020)
Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Andrzej Mackiewicz
The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients. Life (Basel, Switzerland) 10 (10) (2020)
Eliza Kwiatkowska-Borowczyk, Patrycja Czerwinska, Jacek Mackiewicz, Katarzyna Gryska, Urszula Kazimierczak, Katarzyna Tomela, Anna Przybyła, Anna Karolina Kozłowska, Łukasz Galus, Łukasz Kwinta, Ewelina Dondajewska, Agnieszka Gąbka-Buszek, Monika Żakowska, Arkadiusz Ptak
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients. Oncoimmunology 7 (11) (2018)